XML 43 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Measurements  
Tabular disclosure of financial instruments measured at fair value on a recurring basis

 

The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of September 30, 2015:

(in thousands)

 

Level 1

 

Level 2

 

Level 3

 

Total

 

Liability to deliver warrants(1)

 

$

 

$

13,140 

 

$

 

$

13,140 

 

Warrant consideration(1)

 

 

13,490 

 

 

13,490 

 

Tax amortization benefit contingency(2)

 

 

 

147,634 

 

147,634 

 

Deferred acquisition payment(3)

 

 

 

19,436 

 

19,436 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

 

$

26,630 

 

$

167,070 

 

$

193,700 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

These liabilities relate to warrants to purchase the Company's common stock and future obligations to deliver additional such warrants in relation to the Business Combination. The inputs used in the fair value measurement were directly observable quoted prices for identical assets in an inactive market.

(2)

The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company's best estimate of the undiscounted cash payments to be made, tax effected at 37% and discounted to present value utilizing an appropriate market discount rate. The valuation technique used did not change during the two months ended September 30, 2015.

(3)

The fair value of the deferred acquisition payment is measured using a Black-Scholes option pricing model and based on the Company's best estimate of the Company's average adjusted EBITDA level over the two year period from January 1, 2016 to December 31, 2017. The valuation technique used did not change during the two months ended September 30, 2015.

 

Changes in Financial Instruments Measured at Level 3 Fair Value on a Recurring Basis

(in thousands)

 

Tax amortization
benefit
contingency

 

Deferred
acquisition
payment

 

Total

 

Balance, beginning of period

 

$

 

$

 

$

 

Initial recognition at the Closing Date

 

145,174 

 

17,172 

 

162,346 

 

Mark to market adjustment

 

2,460 

 

2,264 

 

4,724 

 

Total realized and unrealized losses

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

147,634 

 

$

19,436 

 

$

167,070